Skip to main content

Blickenstaff Kim D

No open-market purchases or sales filed in the past year.

Current role at each company

Open-market trades in the past year

Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.

Bought
–
0 filings
Sold
–
0 filings
Net
–
Bought minus sold
Companies
0
With open-market trades

Trades

Every Form 4 that lists Blickenstaff Kim D as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.

TNDM Tandem Diabetes Care Inc

Director7 trades

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Nov 22, 2024 (view filing)Nov 20-212 daysBlickenstaff Kim DDirectorSSale−40.0K$31.04−$1.24M−19.5%165.2K after2 lots
May 19, 2022 (view filing)May 172 daysBlickenstaff Kim DDirectorSSale−10.8K$92.91−$999.9K−5.0%205.2K after
Sep 3, 2021 (view filing)Sep 21 dayBlickenstaff Kim DDirectorSSale−28.7K$113.36−$3.25M−12.4%202.4K after2 lots
Aug 18, 2021 (view filing)Aug 16-172 daysBlickenstaff Kim DDirectorSSale−50.0K$108.96−$5.45M−19.8%202.4K after3 lots
Aug 16, 2021 (view filing)Aug 12-134 daysBlickenstaff Kim DDirectorSSale−64.0K$106.83−$6.84M−20.2%252.4K after2 lots
Aug 12, 2021 (view filing)Aug 102 daysBlickenstaff Kim DDirectorSSale−3.21K$107.21−$344.1K−1.0%316.4K after
Aug 10, 2021 (view filing)Aug 6-94 daysBlickenstaff Kim DDirectorSSale−82.8K$107.70−$8.92M−20.6%319.6K after3 lots

NUVB Nuvation Bio Inc.

Director1 trade

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Jun 13, 2024 (view filing)Jun 112 daysBlickenstaff Kim DDirectorPPurchaseClass A Common Stock+172.2K$2.90+$499.3KNew position172.2K after